These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 36106517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.
    Yonekura S, Gotoh M, Okano M, Kurokawa T, Maekawa Y, Okubo K, Okamoto Y.
    Allergol Int; 2022 Jan; 71(1):140-143. PubMed ID: 34509370
    [No Abstract] [Full Text] [Related]

  • 5. Allergen Stability and Immunological Reactivity during Co-dissolution and Incubation of House Dust Mite and Japanese Cedar Pollen SLIT-Tablets.
    Watanabe A, Yamamoto T, Matsuhara H, Matsui H, Nakazawa H, Lund K, Ohashi-Doi K.
    Biol Pharm Bull; 2020 Oct 01; 43(10):1448-1450. PubMed ID: 32759600
    [Abstract] [Full Text] [Related]

  • 6. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May 01; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets.
    Yonekura S, Gotoh M, Kaneko S, Maekawa Y, Okubo K, Okamoto Y.
    J Allergy Clin Immunol Pract; 2021 Nov 01; 9(11):4103-4116.e14. PubMed ID: 34333190
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
    Gotoh M, Yonekura S, Imai T, Kaneko S, Horikawa E, Konno A, Okamoto Y, Okubo K.
    J Allergy Clin Immunol Pract; 2019 Apr 01; 7(4):1287-1297.e8. PubMed ID: 30537561
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis.
    Kurokawa T, Yonekura S, Gotoh M, Okano M, Maekawa Y, Okubo K, Okamoto Y.
    J Allergy Clin Immunol Glob; 2023 May 01; 2(2):100075. PubMed ID: 37780797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recent development on the use of sublingual immunotherapy tablets for allergic rhinitis.
    Waserman S, Shah A, Avilla E.
    Ann Allergy Asthma Immunol; 2021 Aug 01; 127(2):165-175.e1. PubMed ID: 34029713
    [Abstract] [Full Text] [Related]

  • 16. [ENHANCED CLINICAL EFFECTS OF CEDARCURE® TABLETS OF SUBLINGUAL IMMUNOTHERAPY OVER THE YEARS OF TREATMENT AND THE IMPACT OF OUTCOME BY COMBINED USE OF MITE SUBLINGUAL IMMUNOTHERAPY (DUAL SLIT) FOR JAPANESE CEDAR POLLINOSIS].
    Yuta A, Ogawa Y, Murao T, Kozaki H, Shimizu T.
    Arerugi; 2022 Aug 01; 71(9):1122-1128. PubMed ID: 36372423
    [Abstract] [Full Text] [Related]

  • 17. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
    Osada T, Tanaka Y, Yamada A, Sasaki E, Utsugi T.
    Allergol Int; 2018 Oct 01; 67(4):467-474. PubMed ID: 29525489
    [Abstract] [Full Text] [Related]

  • 18. Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
    Gotoh M, Okubo K, Yuta A, Ogawa Y, Nagakura H, Ueyama S, Ueyama T, Kawashima K, Yamamoto M, Fujieda S, Sakashita M, Sakamoto H, Iwasaki N, Mori E, Endo T, Ohta N, Kitazawa H, Okano M, Asako M, Takada M, Terada T, Inaka Y, Yonekura S, Matsuoka T, Kaneko S, Hata H, Hijikata N, Tanaka H, Masuyama K, Okamoto Y.
    Allergol Int; 2020 Jan 01; 69(1):104-110. PubMed ID: 31421989
    [Abstract] [Full Text] [Related]

  • 19. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
    Sakashita M, Yamada T, Imoto Y, Hirota T, Tamari M, Ito Y, Kubo S, Osawa Y, Takahashi N, Fujieda S.
    Cytokine; 2015 Sep 01; 75(1):181-5. PubMed ID: 25934649
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.